Form 20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]:
SEC Accession No. 0001171843-20-002847
Filing Date
2020-04-24
Accepted
2020-04-24 10:43:08
Documents
134
Period of Report
2019-12-31

Document Format Files

Seq Description Document Type Size
1 FORM 20-F f20f_042420.htm 20-F 3183904
2 EXHIBIT 1.1 exh_11.htm EX-1.1 207951
3 EXHIBIT 12.1 exh_121.htm EX-12.1 7322
4 EXHIBIT 12.2 exh_122.htm EX-12.2 7363
5 EXHIBIT 13.1 exh_131.htm EX-13.1 2994
12 GRAPHIC pipe.jpg GRAPHIC 82621
13 GRAPHIC immune.jpg GRAPHIC 34035
14 GRAPHIC one.jpg GRAPHIC 966
15 GRAPHIC cell.jpg GRAPHIC 11976
16 GRAPHIC two.jpg GRAPHIC 964
17 GRAPHIC three.jpg GRAPHIC 1281
18 GRAPHIC monalizumab.jpg GRAPHIC 35081
19 GRAPHIC antitumor.jpg GRAPHIC 56778
20 GRAPHIC trialdesign.jpg GRAPHIC 57138
21 GRAPHIC freesurv1.jpg GRAPHIC 7505
22 GRAPHIC oversurv1.jpg GRAPHIC 8187
23 GRAPHIC freesurv2.jpg GRAPHIC 8221
24 GRAPHIC oversurv2.jpg GRAPHIC 8999
25 GRAPHIC bicr.jpg GRAPHIC 50224
26 GRAPHIC adcc.jpg GRAPHIC 29264
27 GRAPHIC nonrandom.jpg GRAPHIC 42863
28 GRAPHIC iph5401.jpg GRAPHIC 29623
29 GRAPHIC doseesca.jpg GRAPHIC 41026
30 GRAPHIC iph5401_survival.jpg GRAPHIC 32801
31 GRAPHIC iph5401_potency.jpg GRAPHIC 8166
32 GRAPHIC nkp46_nkce.jpg GRAPHIC 15442
33 GRAPHIC nkcell.jpg GRAPHIC 12785
34 GRAPHIC orgchart.jpg GRAPHIC 11054
  Complete submission text file 0001171843-20-002847.txt   17913347

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE FILE inpha-20191231.xml EX-101.INS 4415763
7 XBRL SCHEMA FILE inpha-20191231.xsd EX-101.SCH 169891
8 XBRL CALCULATION FILE inpha-20191231_cal.xml EX-101.CAL 54508
9 XBRL DEFINITION FILE inpha-20191231_def.xml EX-101.DEF 723481
10 XBRL LABEL FILE inpha-20191231_lab.xml EX-101.LAB 736769
11 XBRL PRESENTATION FILE inpha-20191231_pre.xml EX-101.PRE 791244
Mailing Address 117 AVENUE DE LUMINY BP 30191 MARSEILLE I0 13009
Business Address 117 AVENUE DE LUMINY BP 30191 MARSEILLE I0 13009 33430303030
Innate Pharma SA (Filer) CIK: 0001598599 (see all company filings)

EIN.: 000000000 | State of Incorp.: I0 | Fiscal Year End: 1231
Type: 20-F | Act: 34 | File No.: 001-39084 | Film No.: 20813173
SIC: 2836 Biological Products, (No Diagnostic Substances)